PhRMA is a major trade group representing biopharmaceutical companies in the United States. It lobbies Congress to protect patent rights for drug makers and to influence policies affecting Medicare and Medicaid, including Medicare Part B. The filings show it spent about $120,000 across four filings most recently in January 2026 and used the law firm Nelson Mullins Riley & Scarborough.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
RON KLINK
The latest disclosures for this client.
NELSON MULLINS RILEY & SCARBOROUGH
Q2NELSON MULLINS RILEY & SCARBOROUGH
Q1The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
NELSON MULLINS RILEY & SCARBOROUGH
NELSON MULLINS RILEY & SCARBOROUGH
Q4NELSON MULLINS RILEY & SCARBOROUGH
Q3NELSON MULLINS RILEY & SCARBOROUGH
Q2NELSON MULLINS RILEY & SCARBOROUGH
Q1